Plasma fatty acids, adiposity, and variance of skeletal muscle insulin resistance in type 2 diabetes mellitus

Journal of Clinical Endocrinology and Metabolism

Volumn 86, Issue 11, 2001, Pages 5412-5419

  Kelley, David E ^a,b   Williams, Katherine V ^a   Price, Julie C ^a   Mckolanis, Therese M ^a   Goodpaster, Bret H ^a   Thaete, F Lee ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FATTY ACID; INSULIN;

ADULT; AGED; ARTICLE; BODY MASS; CLINICAL ARTICLE; DISEASE SEVERITY; FATTY ACID BLOOD LEVEL; FEMALE; HUMAN; INSULIN RESISTANCE; LIPOLYSIS; MALE; MUSCLE MASS; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PRIORITY JOURNAL; SKELETAL MUSCLE;

EID: 0035176351     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jcem.86.11.8027     Document Type: Article

References (43)

1. The ghicose fatty-acid cycle. Its role in insulin sensitivity and the metabolic disturbances of diabetes mellitus
2. Effects of fat on insulin-stimulated carbohydrate metabolism in normal men
3. Role of fatty acids in the pathogenesis of insulin resistance in NIDDM
4. Interaction between glucose and free fatty acid metabolism in human skeletal muscle
5. Effects of an acute decrease in non-esterified fatty acid levels on muscle glucose utilization and forearm indirect calorimetry in lean NIDDM subjects
6. Free fatty acid-induced insulin resistance is associated with activation of protein kinase C and alterations in the insulin signaling cascade
7. Acyl-CoA inhibition of hexokinase in rat and human skeletal muscle is a potential mechanism of lipid-induced insulin resistance
8. Mechanisms of fatty acid-induced inhibition of glucose uptake
9. Mechanism of free fatty acid-induced insulin resistance in humans
10. Mechanisms of non-insulin dependent diabetes mellitus
11. Overnight lowering of free fatty acids with acipimox improves insulin resistance and glucose tolerance in obese diabetic and non-diabetic subjects
12. Effects of fat on glucose uptake and utilization in patients with non-insulin-dependent diabetes mellitus
13. The effect of non-insulin-dependent diabetes mellitus and obesity on glucose transport and phosphorylation in skeletal muscle
14. Relationship of body fat topography to insulin sensitivity and metabolic profile in premenopausal women
15. Relationship of generalized and regional adiposity to insulin sensitivity in men with NIDDM
16. Does intra-abdominal adipose tissue in black men determine whether NIDDM is insulin resistant or insulin sensitive?
17. Impact of obesity on insulin action in NIDDM
18. Effect of obesity on insulin resistance in normal subjects and patients with NIDDM
19. Reproducibility of computed tomography measurement of visceral adipose tissue area
20. Subdivisions of subcutaneous abdominal adipose tissue and insulin resistance
21. Skeletal muscle glycolytic and oxidative enzyme capacities are determinants of insulin sensitivity and muscle composition in obese women
22. ECAT ART-a continuously rotating PET camera: Performance characteristics, initial clinical studies, and installation considerations in a nuclear medicine department
23. A single scatter simulation technique for scatter correction in 3-D PET
24. Model-based scatter correction for fully 3-D PET
25. Insulin regulation of glucose transport and phosphorylation in skeletal muscle assessed by positron emission tomography
26. Graphical evaluation of blood-to-brain transfer constants from multiple-time uptake data
27. Simple noninvasive quantification method for measuring myocardial glucose utilization employing positron emission tomography and flourine-18 deoxyglucose
28. Subcutaneous abdominal fat and thigh muscle composition predict insulin sensitivity independently of visceral fat
29. Relationship of visceral adipose tissue and glucose disposal is independent of sex in black NIDDM subjects
30. The perils of portliness: Causes and consequences of visceral adiposity
31. The quantitatively minor role of carbohydrate in oxidative metabolism by skeletal muscle in intact man in the basal state
32. Effect of insulin on skeletal muscle glucose storage, oxidation, and glycolysis in humans
33. Skeletal muscle utilization of free fatty acids in women with visceral obesity
34. Fuel selection in human skeletal muscle in insulin resistance: A reexamination
35. Roles of glucose transport and glucose phosphorylation in muscle insulin resistance of NIDDM
36. Decreased muscle glucose transport/phosphorylation is an early defect in the pathogenesis of non-insulin-dependent diabetes mellitus
37. Impaired glucose transport as a cause of decreased insulin-stimulated muscle glycogen synthesis in type 2 diabetes
38. Glucose-free fatty acid cycle operates in human heart and skeletal muscle in vivo
39. 18F]FDG in human skeletal muscle
40. Thigh adipose tissue distribution is associated with insulin resistance and obesity in type 2 diabetes mellitus
41. Skeletal muscle triglyceride: An aspect of regional adiposity and insulin resistance
42. Intramuscular lipid content is increased in obesity and decreased by weight loss
43. Skeletal muscle attenuation determined by computed tomography is associated with skeletal muscle lipid content